View article

The number of confirmed cases of coronavirus dis-ease 2019 (COVID-19) has exceeded 1,500,000 cases globally1 and is expected to increase over time, with no signs of the virus abating any time soon. Patients with neurological diseases, particularly those with prior cerebrovascular diseases and immunocompromised patients, are at higher risk of complications when infected by the virus. 2 Furthermore, recent studies from China and Italy report that approximately 36% of patients with COVID-19 exhibit neurological symptoms. 3 Since the COVID-19 pandemic, and due to the high rate of healthcare provider infections as well as the risk of worse outcomes when patients with neurological diseases are infected, the use of telemedicine has expanded and optimized to continue to provide care to patients and minimize the risk of infection to both patients and healthcare providers.

One of the main uses for telemedicine in …